← All indications
Genes, erbB-2
The erbB-2 gene is a proto-oncogene that codes for the erbB-2 receptor (ERB-B2 RECEPTOR TYROSINE KINASES), a protein with structural features similar to the epidermal growth factor receptor. Its name originates from the viral oncogene homolog (v-erbB) which is a truncated form of the chicken erbB gene found in the avian erythroblastosis virus. Overexpression and amplification of the gene is associated with a significant number of adenocarcinomas. The human c-erbB-2 gene is located at 17q21.2.
Drugs by status
Phase 3 trials (5)
Phase 2 trials (28)
- afatinib
- avelumab
- bacille calmette-guerin
- irinotecan
- fluorouracil
- paclitaxel
- nivolumab
- leucovorin
- mm-111
- osimertinib
- pemetrexed
- trastuzumab
- pyrotinib
- cetuximab
- zoledronic acid
- Zanidatamab
- her-2 car-t cells
- docetaxel
- oxaliplatin
- a166
- fam-trastuzumab deruxtecan-nxki
- tislelizumab
- simmitinib
- her2 dc1 vaccine
- snk01
- DP303c
- almonertinib
- furmonertinib